Standard antibiotic prophylaxis — Competitive Intelligence Brief

Standard antibiotic prophylaxis (Standard antibiotic prophylaxis) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antibiotic (class varies by specific agent). Area: Infectious Disease / Prophylaxis.

phase 3 Antibiotic (class varies by specific agent) Infectious Disease / Prophylaxis Small molecule

Target snapshot

Standard antibiotic prophylaxis (Standard antibiotic prophylaxis) — Western Galilee Hospital-Nahariya. Standard antibiotic prophylaxis prevents bacterial infections by inhibiting bacterial cell wall synthesis or protein production before infection occurs.

Comparator set (2 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Standard antibiotic prophylaxis TARGET	Standard antibiotic prophylaxis	Western Galilee Hospital-Nahariya	phase 3	Antibiotic (class varies by specific agent)
Typically prescribed oral antibiotic prophylaxis	Typically prescribed oral antibiotic prophylaxis	Women and Infants Hospital of Rhode Island	marketed	Antibiotic (class varies by specific agent)
Antibiotic administration	Antibiotic administration	University of California, San Diego	phase 3	Antibiotic (class varies by specific agent)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antibiotic (class varies by specific agent) class)

1. University of California, San Diego · 1 drug in this class
2. Western Galilee Hospital-Nahariya · 1 drug in this class
3. Women and Infants Hospital of Rhode Island · 1 drug in this class